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translations based on analysis of qualitative data collected during pilot-testing. 
In an effort to create a universal Spanish version, linguists from various Spanish-
speaking countries were recruited to achieve a translation that could be used in 
all regions in which Spanish is spoken. Results: After the translation phase was 
completed, psychometric testing was carried out. 485 adult items and 139 pediatric 
items from 11 subdomains were tested with native Spanish speakers (2,500 adults 
and 1,200 children) from an online general population panel. Different item banks 
exhibited various levels of differential item functioning (DIF) across Spanish and 
English speaking populations. In order to retain all items in each bank, a hybrid 
approach was used in which English calibration metrics were used for non-DIF 
items and Spanish calibrations were used for items exhibiting DIF. ConClusions: 
Spanish Computer Adaptive Tests (CATs) for Anxiety, Depression, Fatigue, Physical 
Function and Sleep Disturbance are currently available in Assessment Center (www.
assessmentcenter.net).
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PrelImInary results QualIty of lIfe, PHysIcal actIvIty, and 
sedentary BeHavIor In college students
Mendoza F.J., Parra G., Bastardo Y.M.
Universidad Central de Venezuela, Caracas, Venezuela
objeCtives: Being physically active is associated with reduced risk of chronic 
diseases. In this study we examined the associations of physical activity and 
sedentary behavior with perceived quality of life (QoL) in college students in 
Venezuela. Methods: A convenience sample of 64 students at Central University 
of Venezuela, ranging in age from 17 to 43 years was surveyed using a written 
questionnaire. Quality of life was measured using a single-item from the Health 
Survey Short-Form 36 (SF-36), EuroQol health states descriptive system (EQ-5D), 
and a visual analogue scale (EQ-VAS). The relationships between health status, 
physical activity, and sedentary behavior were estimated computing Kendall’s τ 
correlation coefficients. Statistic analysis was performed by SPSS 13.0. Results: 
The sample consisted of 41 females and 22 males. The sample had a mean age of 
20.54 years (s.d. 3.99 years). Two subjects (3.2%) reported some problems with mobil-
ity. Three subjects (4.8%) reported some problems with usual activity. Ten subjects 
(15.9%) reported some problems with pain. One subject (1.6%) reported extreme 
problems and 10 reported some problems with anxiety. Three subjects (4.8%) rated 
health status of fair or poor. Subjects reported doing vigorous physical activities on 
a mean of 2.05 days during the past week. Subjects reported walking for a mean of 
93.49 minutes during the past week. Subjects reported spending a mean of 301.31 
minutes sitting during the past week. Neither physical activity nor sedentary behav-
ior was associated with quality of life in our population. ConClusions: Study 
limitations include the sample size and the use of a convenient sample. Overall, 
this exploratory study demonstrates that the quality of life of college students in 
Venezuela was good.
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objeCtives: Equity is a desirable goal for health systems performance and the 
comparison of them is important to learn lessons from the best. In the present study 
our goal was to analyze comparatively inequalities in health and the influence of 
social determinants of health in two countries with different social, economical 
and political contexts: Cuba and USA. Methods: A compared inequalities analy-
sis was made in three health indicators related with the performance of health 
systems: maternal mortality rate (MMR), infant mortality rate (IMR) and life expec-
tancy at birth (LEB) using published geopolitical unities information from USA 
and Cuba in 2008 and through the computation of inequality indexes suggested 
in literature and statistical analysis. Also there were comparatively analyzed the 
effects on these health indicators of three proxy indicators of social determinants 
of health (PISDH’s): percent of rural population (PRP), percent of non white popula-
tion (PNW) and physicians rate (PHR), through the computation of effect indexes 
for significantly Pearson correlations. Results: Cuba showed significantly higher 
inequality than USA in MMR; USA showed higher inequality in LEB; the inequality 
in IMR was statistically not different. The PRP was a risk factor for the LEB in USA 
but a protector factor in Cuba; PNW was a risk factor for MMR and IMR in USA only, 
although with low effect index; PHR was a risk factor for MMR in USA only, perhaps 
by his correlation with another PISDH’s. ConClusions: Important inequalities 
were identified in both countries. The PISDH’s analyzed affected health indica-
tors principally in USA. Another economic PISDH’s are required for more detailed 
comparative analysis in the effects of PISDH’s in health inequalities. There are few 
comparative analysis of health systems in the literature that employ quantitative 
methodology as used in this study.
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objeCtivos: Estimar los costos de atención del parto vaginal en unidades del 
sector público de salud de Oaxaca y Chiapas, para dos modelos asistenciales 
alternativos (convencional e intercultural), durante 2008-2012 e identificar los 
principales determinantes de la implementación efectiva y puesta a escala de 
modelos interculturales de atención materna en beneficio de la población indí-
23.5%), and pharmacy records (n= 7, 8.6%). Different versions of the Morisky test 
were identified (modified, 4-item, and 8-item). Other validated adherence ques-
tionnaires identified within the studies (with more than one occurence) were: 
MAT (n= 3) and MedTake (n= 2). Pill counting, medical chart review, and serum drug 
determination were used in 4 studies each. None study used electronic monitoring 
of adherence. ConClusions: Data from the available Brazilian studies indicate a 
variety of methods adopted by local researchers for measuring adherence to treat-
ment. Indirect measures are more common, particularly those based on patients’ 
or caregivers’ perception of adherence behaviors. Most studies enrolled HIV/AIDS 
or hypertension patients. Other chronic conditions with long term continuous oral 
therapies were underrepresented.
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objeCtives: To determine if the tool Prometex – Promevoz, helps in reducing the 
drug therapy use problems identified in the Pharmacotherapy Monitoring for 
pharmaceutics. Methods: Prometex – Promevozis a tool for telephony (voice 
and text messages) you want, combined with other strategies, to maintain and 
increase drug compliance, remembering the exact times of taking medication. 
With prior consent, information is sent to all medications they are prescribed, 
coded for strictly personal interpretation and handling of confidential and bidi-
rectional. A descriptive longitudinal, which includes users with at least two visits 
to Pharmacotherapy Monitoring, a pre and post-deployment of telephony tool. 
Demographic variables are analyzed and compared in an exploratory way in the 
same population type and amount of drug therapy use problems at the begin-
ning and end of use of the tool. Results: A total of 25.6% of patients had at least 
1 drug therapy use problems during the first consultation of Pharmacotherapy 
Monitoring, a situation that changed after the use of Prometex – Promevoz, which 
decreased the proportion of patients with drug therapy use problems to 16.7%. 
A decrease between the two observations of 53.3% with a chi squeare (ji2) of 9,56 
and a p value of 0,002. ConClusions: The tool Prometex – Promevoz appears 
to contribute to the decline in drug therapy use problemsidentified in the 
Pharmacotherapy Monitoring.
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objeCtives: Increasing competition, pressure from payers and greater regulatory 
constraints require pharmaceutical manufacturers to seek methods for product 
differentiation. One way of differentiating pharmaceuticals is the generation of 
patient-centric value messages utilizing patient-reported outcomes (PROs). PROs 
may be primary or nonprimary endpoints in clinical trials, and commercial use is 
typically dependent on PROs that support key endpoints and appear in labeling 
(US) or in the summary of product characteristics (EU) to support reimbursement. 
However, despite this obvious utility, the cost and logistical complexity of including 
PROs may deter clinical teams. The purpose of this research is to better understand 
the value of PROs and the ability of PROs to provide data critical to decision making 
for patients, clinicians, and payers. Methods: A detailed case study was conducted 
of three marketed products: ivacaftor, mirabegron, and botulinum type A. Selection 
of these products represent a range of therapeutic areas and may provide insight 
into the differing roles of PROs. For each product available US and European sub-
mission and review documents were analyzed. Results: PROs were included in 
all three submissions. A PRO labeling claim was granted for a primary endpoint for 
mirabegron, and while claims for nonprimary PROs were denied, the review docu-
ments indicate that the decision for drug approval was supported by results of the 
nonprimary endpoints. Ivacaftor was granted a claim based on a nonprimary PRO 
endpoint, though the tool did not meet the specifications of the FDA’s PRO guidance. 
Finally, health authorities recognized the impact on health-related quality of life for 
botulinum type A for migraine in support of a positive appraisal. ConClusions: 
The results of this review indicate that PROs included in clinical trials may have a 
strong influence on the drug approval process, regardless of whether a PRO labeling 
claim is ultimately granted. Further research is warranted.
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objeCtives: The Patient-Reported Outcomes Measurement Information System 
(PROMIS®) provides accurate and efficient measurement of patient-reported out-
comes. Developed in English using qualitative methods, PROMIS tools measure 
symptoms, such as pain and fatigue, and aspects of health-related quality of life 
across a wide variety of chronic diseases and conditions. Methods: To enable 
participation of Spanish-speaking populations the PROMIS banks were translated 
into Spanish using methods that would ensure linguistic equivalence and cultural 
appropriateness. The Spanish translation of 825 adult and 156 pediatric items was 
obtained through the FACIT Multilingual Translation Methodology which consists 
of the following ten steps: 1) creation of item definitions; 2) two simultaneous for-
ward translations; 3) reconciliation of forward translations; 4) back-translation of 
reconciliation; 5) expert review of back-translation and previous steps; 6) prelimi-
nary finalization for pilot-testing; 7) cross-cultural harmonization; 8) quality assur-
ance; 9) cognitive testing with native speakers of Spanish; and 10) finalization of 
